Breast Cancer
Breast Cancer
Kelly Pabst, MSN, APRN, ACNS-BC, AOCNSVideos | May 1, 2023
Kelly Pabst, MSN, APRN, ACNS-BC, AOCNS discusses early detection and prevention of lymphedema in breast cancer patients.
View More
Dustin SamplesTreatment | April 28, 2023
Linda Buck led a information session on sacituzumab govitecan-hziy at ONS 2023.
Dustin SamplesConferences | April 27, 2023
Accelerated approvals will no longer be granted based on overall response rates in single-arm trials.
Teresa Hagan Thomas, PhD, RNPatient Voice | April 25, 2023
The program resulted in high patient satisfaction, good compliance, and lower costs than traditional in-person visits.
Teresa Hagan Thomas, PhD, RNBreast Cancer | March 30, 2023
In general, women preferred exercise partners with a similar diagnosis, location, age, and fitness goal.
Dustin SamplesBreast Cancer | February 15, 2023
The treatment group demonstrated increased quality of life, but did acupuncture affect myelosuppression?
Dustin SamplesBreast Cancer | February 8, 2023
Substituting physical activity for sedentary time is beneficial, but how much is enough?
Dustin SamplesBreast Cancer | January 24, 2023
Women with breast cancer who had lower perceptions of their cognitive abilities tended to have more anxiety or depression.
Dustin SamplesPatient Voice | January 9, 2023
Video games are fun, but can a new 'serious game' help women with breast or gynecologic cancer self-advocate?
Dustin SamplesNews | January 5, 2023
Battle and war metaphors are common in the cancer experience. But do they help or hurt?
Emily MenendezTreatment | January 3, 2023
Reduced auditory function is common with taxane- and platinum-based treatments. Here's how you can help your patients.
Emily MenendezBreast Cancer | January 3, 2023
Though treatment has improved, outcomes have diverged since the mid-1980s. What can be done?
Emily MenendezBreast Cancer | December 22, 2022
Hormone replacement therapy is common, but is it safe? What are the risks of estrogen and progesterone therapy?
Leah LawrenceBreast Cancer | December 20, 2022
The local recurrence rates were optimistic for women with multiple ipsilateral breast cancer in one clinical trial.
Leah LawrenceBreast Cancer | December 20, 2022
Results from the DESTINY-Breast03 study indicate survival advantage with the antibody drug conjugate.
Leah LawrenceBreast Cancer | December 20, 2022
Gene recurrence-score trial finds puzzling disparities in outcomes despite similarities in clinical factors.
Leah LawrenceBreast Cancer | August 23, 2022
Nurse-led telephone-based consultations for adjuvant endocrine therapy may increase adherence.
Leah LawrenceConferences | June 16, 2022
Improving access to evidence-based information for caregivers could improve outcomes for patients with breast cancer.
Kerri FitzgeraldConferences | June 14, 2022
Just 38% of patients with breast cancer receive at least 1 palliative care consult following metastatic disease diagnosis.
Kerri FitzgeraldConferences | June 14, 2022
All stakeholders have a role to play in increasing representation in this patient population.